Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-19T07:22:44.475Z Has data issue: false hasContentIssue false
  • English
  • Français

Reduced Use of Third-Generation Cephalosporins Decreases the Acquisition of Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae

Published online by Cambridge University Press:  02 January 2015

Sang-Oh Lee ,
Eun Sun Lee ,
Shin Young Park ,
Sue-Yun Kim ,
Yiel-Hae Seo  and
Yong Kyun Cho
Sang-Oh Lee
Affiliation:
Division of Infectious Diseases, Gil Medical Center, Gachon Medical School, Incheon, Korea
Eun Sun Lee
Affiliation:
Infection Control Unit, Gil Medical Center, Gachon Medical School, Incheon, Korea
Shin Young Park
Affiliation:
Infection Control Unit, Gil Medical Center, Gachon Medical School, Incheon, Korea
Sue-Yun Kim
Affiliation:
Division of Infectious Diseases, Gil Medical Center, Gachon Medical School, Incheon, Korea
Yiel-Hae Seo
Affiliation:
Department of Laboratory Medicine, Gil Medical Center, Gachon Medical School, Incheon, Korea
Yong Kyun Cho*
Affiliation:
Division of Infectious Diseases, Gil Medical Center, Gachon Medical School, Incheon, Korea
*
Division of Infectious Diseases, Gil Medical Center, Gachon Medical School, 1198 Guwol-dong, Namdong-gu, Incheon 405-760, Korea
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives:

To identify risk factors for the respiratory acquisition of extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae among patients admitted to a neurosurgical intensive care unit (NSICU) and to modify them without changing general infection control measures.

Design:

Nested case-control and intervention study.

Setting:

A 1,200-bed, tertiary-care teaching hospital with a 17-bed NSICU.

Methods:

Sputa of all patients admitted to the NSICU were cultured weekly during the study. From October 2002 through February 2003, 29 case-patients from whose sputum ESBL-producing K. pneumoniae was isolated were detected and 59 controls-patients were randomly selected among patients without any positive isolate of ESBL-producing K. pneumoniae. After analyzing the risk factors, we intervened to modify them and compared the acquisition rate of ESBL-producing K. pneumoniae before (October 2002 to February 2003) and after (April to August 2003) the intervention.

Results:

Multivariate analysis showed that prior exposure to third-generation cephalosporins (TGCs) (OR, 6.0; CI95, 1.9 to 18.6; P= .002) was an independent risk factor of ESBL-producing K. pneumoniae acquisition. The neurosurgical team was notified of the result, and the infectious diseases specialist visited the NSICU three times a week to regulate TGC use during the intervention period. Patients admitted before the intervention were older than patients admitted after. The respiratory acquisition of ESBL-producing K. pneumoniae per 1,000 patient-days (13.5 [CI95, 8.9 to 18.1] vs 2.7 [CI95, 0.9 to 4.6]) and the antimicrobial use density of TGCs (38.2 ± 5.0 vs 17.3 ± 2.6; P < .001) decreased significantly after the intervention.

Conclusion:

Prior exposure to TGCs was an independent risk factor for the respiratory acquisition of ESBL-producing K. pneumoniae, and less use of TGCs was associated with a decrease in acquisition.

Type
Orginal Articles
Information
Infection Control & Hospital Epidemiology , Volume 25 , Issue 10 , October 2004 , pp. 832 - 837
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2004 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Bush, K, Jacoby, GA, Medeiros, AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39:1211–1233.10.1128/AAC.39.6.1211Google Scholar
2. Nouvellon, M, Pons, JL, Sirot, D, Combe, ML, Lemeland, JF. Clonal outbreaks of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae demonstrated by antibiotic susceptibility testing, beta-lactamase typing, and multilocus enzyme electrophoresis. J Clin Microbiol 1994;32:2625–2627.10.1128/jcm.32.10.2625-2627.1994Google Scholar
3. Rice, LB, Willey, SH, Papanicolaou, GB, et al. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990;34:2193–2199.10.1128/AAC.34.11.2193Google Scholar
4. Ayan, M, Kuzucu, C, Durmaz, R, Aktas, E, Cizmeci, Z. Analysis of three outbreaks due to Klebsiella species in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003;24:495–500.10.1086/502245Google Scholar
5. Meyer, KS, Urban, C, Eagan, JA, Berger, BJ, Rahal, JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353–358.10.7326/0003-4819-119-5-199309010-00001Google Scholar
6. Peña, C, Pujol, M, Ardanuy, C, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1998;42:53–58.10.1128/AAC.42.1.53Google Scholar
7. Patterson, JE, Hardin, TC, Kelly, CA, Garcia, RC, Jorgensen, JH. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae . Infect Control Hosp Epidemiol 2000;21:455–458.Google Scholar
8. Rice, LB, Eckstein, EC, DeVente, J, Shlaes, DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996;23:118–124.10.1093/clinids/23.1.118Google Scholar
9. Rahal, JJ, Urban, C, Horn, D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella . JAMA 1998;280:1233–1237.Google Scholar
10. Asensio, A, Oliver, A, González-Diego, P, et al. Outbreak of a multiresis-tant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis 2000;30:55–60.10.1086/313590Google Scholar
11. Lin, MF, Huang, ML, Lai, SH. Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan. J Hosp Infect 2003;53:39–45.10.1053/jhin.2002.1331Google Scholar
12. Pessoa-Silva, CL, Moreira, BM, Almeida, VC, et al. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: risk factors for infection and colonization. J Hosp Infect 2003;53:198–206.10.1053/jhin.2002.1373Google Scholar
13. Jarlier, V, Nicolas, MH, Fournier, G, Philippon, A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867–878.10.1093/clinids/10.4.867Google Scholar
14. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: National Committee for Clinical Laboratory Standards; 2003. Approved standard M7-A6.Google Scholar
15. Fridkin, SK, Steward, CD, Edwards, JR, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Clin Infect Dis 1999;29:245–252.Google Scholar
16. Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.10.1016/0196-6553(88)90053-3Google Scholar
17. Rice, LB. Controlling antibiotic resistance in the ICU: different bacteria, different strategies. Cleve Clin J Med 2003;70:793–800.10.3949/ccjm.70.9.793Google Scholar